Discontinued — last reported Q3 '25
ResMed Distributions from equity method investments remained flat by 0.0% to $911.00K in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 297.2%, from -$462.00K to $911.00K. Over 3 years (FY 2022 to FY 2025), Distributions from equity method investments shows an upward trend with a -24.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals successful capital allocation and returns from strategic partnerships.
Cash received from unconsolidated affiliates or entities accounted for under the equity method. This represents actual c...
Common for holding companies with diverse investment portfolios.
distributions_from_equity_investments| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | -$8.49M | -$10.14M | -$1.85M | $3.64M |
| YoY Change | — | -19.5% | +81.8% | +297.2% |